Navigation Links
Big Pharma Chemists Turning Out in Large Numbers for ChemOutsourcing Extravaganza Event on September 14-16, 2010 at Jersey Shore Beach Resort
Date:7/27/2010

LONG BRANCH, N.J., July 27 /PRNewswire/ -- For the first time ever, large numbers of personnel from the world's largest pharmaceutical companies have been registering to attend Pharma ChemOutsourcing at the Jersey Shore this fall. Most are chemists by training and work in the exploding field of outsourcing/sourcing active pharmaceutical ingredients (API's).

Pharma ChemOutsourcing has found a home on the East Coast where the majority of the large pharmaceutical companies and their suppliers are located. "We have good working relationships with Pfizer, Merck, Bristol-Myers Squibb, Eli Lilly, Roche, GSK, and Novartis, for example, and they often provide guidance to make the show more relevant to their current needs," Alexay continued. "We get a lot of input".

"The event is growing at a 35% rate this year," says Mark Alexay the event organizer, "but what distinguishes this year's attendance is that the large pharma companies are coming in much greater numbers than years past. This is evident in the sharply higher turnout from the respective companies. The Big Pharma attendees say that it's a convenient place to accomplish several high priority goals in a short period of time – there's a LOT of information in the conference sessions plus they meet their suppliers."

The event features 4 parallel tracks over 3 days, 150 speakers, 100 exhibitors, 1000 attendees, and is studded with nightly socializing events on the beach for effective networking. "People set up meetings before the show but the evening parties over several nights help people make new connections. It's much easier to approach someone new in a social setting away from the conference hotel," remarked Alexay.

The 2010 attendee list may be viewed at http://chemoutsourcing.com/attendees.php

The 100 exhibitors are at http://chemoutsourcing.com/sponsors.php

The 2009 Beach Party can be viewed at http://www.youtube.com/watch?v=zTGzZhqDjcU&feature=fvw

For additional information about the extravaganza chemistry event visit www.chemoutsourcing.com or contact Mark Alexay at +1-201-452-4023, or malexay@chemoutsourcing.com


'/>"/>
SOURCE Apaporis LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
5. Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management
6. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
7. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
8. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
9. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
10. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
11. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... DUBLIN , Feb 24, 2017 Research ... Drugs Price Analysis and Strategies - 2016" report to their ... The ... provides drug pricing data and benchmarks in the global Urinary Incontinence ... What are the key drugs marketed for Urinary Incontinence ...
(Date:2/23/2017)... -- Cogentix Medical, Inc. (NASDAQ: CGNT), a medical device company ... the urology market, will release financial results for the ... before the market open on Thursday, March 9, 2017. ... call and webcast to discuss its financial results the ... a.m. Eastern Time (10:00 a.m. Central Time). Darin ...
(Date:2/23/2017)... 23, 2017 Research and Markets has announced ... Strategies - 2016" report to their offering. ... The latest research Oesophageal Cancer ... and benchmarks in the global Oesophageal Cancer market. The ... are the key drugs marketed for Oesophageal Cancer and their clinical ...
Breaking Medicine Technology:
(Date:2/24/2017)... ... February 24, 2017 , ... Rosica ... in thought leadership , media relations, social media, content marketing and SEO, ... be powered through Act-On, an intuitive marketing automation platform. , Rosica will now ...
(Date:2/23/2017)... ... 23, 2017 , ... On February 22, 2017 the U.S. ... to withdraw previous guidance issued by the Obama Administration requiring schools to treat ... 2016 by the Obama Administration came in response to a growing number of ...
(Date:2/23/2017)... , ... February 23, 2017 , ... The American Cleft ... ACPA’s 74th Annual Meeting. KLS is a longtime supporter of the event. , ... exhibitor and Platinum Sponsor," said Dr. Bob Havlik, 2017 ACPA President. "KLS Martin has ...
(Date:2/23/2017)... ... February 23, 2017 , ... EBSCO Information Services ... Institute for Health and Care Excellence (NICE) framework. The agreement allows purchasers ... (NHS) to search, order and purchase medical and healthcare-related content through GOBI ...
(Date:2/23/2017)... ... , ... ERT, a global data and technology company that ... leading clinical development service provider, has selected ERT’s Trial Oversight suite as its ... to an array of circumstances including the use of multiple data capture modalities ...
Breaking Medicine News(10 mins):